Anthony Cammarato

Dr. Anthony Cammarato


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2015 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
GKGaurav Kaushik
Gaurav Kaushik
ASAlice Spenlehauer
Alice Spenlehauer
ASAyla O. Sessions
Ayla O. Sessions
ATAdriana S. Trujillo
Adriana S. Trujillo
AFAlexander Fuhrmann
Alexander Fuhrmann
AEAdam J. Engler
Adam J. Engler
The human heart is capable of functioning for decades despite minimal cell turnover or regeneration, suggesting that molecular alterations help sustain heart function with age. However, identification of compensatory remodeling events in the aging heart remains elusive. We present the cardiac proteomes of young and old rhesus monkeys and rats, from which we show that certain age-associated remodeling events within the cardiomyocyte cytoskeleton are highly conserved and beneficial rather than deleterious. Targeted transcriptomic analysis in Drosophila confirmed conservation and implicated vinculin as a unique molecular regulator of cardiac function during aging. Cardiac-restricted vinculin overexpression reinforced the cortical cytoskeleton and enhanced myofilament organization, leading to improved contractility and hemodynamic stress tolerance in healthy and myosin-deficient fly hearts. Moreover, cardiac-specific vinculin overexpression increased median life span by more than 150% in flies. A broad array of potential therapeutic targets and regulators of age-associated modifications, specifically for vinculin, are presented. These findings suggest that the heart has molecular mechanisms to sustain performance and promote longevity, which may be assisted by therapeutic intervention to ameliorate the decline of function in aging patient hearts.

17 January 2014 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MVMeera Cozhimuttam Viswanathan
Meera Cozhimuttam Viswanathan
GKGaurav Kaushik
Gaurav Kaushik
AEAdam J. Engler
Adam J. Engler
WLWilliam Lehman
William Lehman
ACAnthony Cammarato
Anthony Cammarato
Rationale: Regulation of striated muscle contraction is achieved by Ca2+-dependent steric modulation of myosin cross-bridge cycling on actin by the thin filament troponin–tropomyosin complex. Alterations in the complex can induce contractile dysregulation and disease. For example, mutations between or near residues 112 to 136 of cardiac troponin-T, the crucial TnT1 (N-terminal domain of troponin-T)–tropomyosin-binding region, cause cardiomyopathy. The Drosophila upheld101 Glu/Lys amino acid substitution lies C-terminally adjacent to this phylogenetically conserved sequence. Objective: Using a highly integrative approach, we sought to determine the molecular trigger of upheld101 myofibrillar degeneration, to evaluate contractile performance in the mutant cardiomyocytes, and to examine the effects of the mutation on the entire Drosophila heart to elucidate regulatory roles for conserved TnT1 regions and provide possible mechanistic insight into cardiac dysfunction. Methods and Results: Live video imaging of Drosophila cardiac tubes revealed that the troponin-T mutation prolongs systole and restricts diastolic dimensions of the heart, because of increased numbers of actively cycling myosin cross-bridges. Elevated resting myocardial stiffness, consistent with upheld101 diastolic dysfunction, was confirmed by an atomic force microscopy–based nanoindentation approach. Direct visualization of mutant thin filaments via electron microscopy and 3-dimensional reconstruction resolved destabilized tropomyosin positioning and aberrantly exposed myosin-binding sites under low Ca2+ conditions. Conclusions: As a result of troponin–tropomyosin dysinhibition, upheld101 hearts exhibited cardiac dysfunction and remodeling comparable to that observed during human restrictive cardiomyopathy. Thus, reversal of charged residues about the conserved tropomyosin-binding region of TnT1 may perturb critical intermolecular associations required for proper steric regulation, which likely elicits myopathy in our Drosophila model.

1 July 2019 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
ABAnna C. Blice-Baum
Anna C. Blice-Baum
Maria Clara GuidaMaria Clara Guida
Maria Clara Guida
PHPaul S. Hartley
Paul S. Hartley
PAPeter D. Adams
Peter D. Adams
RBRolf Bodmer
Rolf Bodmer
ACAnthony Cammarato
Anthony Cammarato

28 April 2015 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
MVMeera C. Viswanathan
Meera C. Viswanathan
ABAnna C. Blice-Baum
Anna C. Blice-Baum
WSWilliam Schmidt
William Schmidt
DFD. Brian Brian Foster
D. Brian Brian Foster
ACAnthony Cammarato
Anthony Cammarato
In striated muscle tropomyosin (Tm) extends along the length of F-actin-containing thin filaments. Its location governs access of myosin binding sites on actin and, hence, force production. Intermolecular electrostatic associations are believed to mediate critical interactions between the proteins. For example, actin residues K326, K328 and R147 were predicted to establish contacts with E181 of Tm. Moreover, K328 also potentially forms direct interactions with E286 of myosin when the motor is strongly bound. Recently, LC-MS/MS analysis of the cardiac acetyl-lysine proteome revealed K326 and K328 of actin were acetylated, a post-translational modification (PTM) that masks the residues’ inherent positive charges. Here, we tested the hypothesis that by removing the vital actin charges at residues 326 and 328, the PTM would perturb Tm positioning and/or strong myosin binding as manifested by altered skeletal muscle function and structure in the Drosophila melanogaster model system. Transgenic flies were created that permit tissue-specific expression of K326Q, K328Q, or K326Q/K328Q acetyl-mimetic actin and of wild-type actin via the UAS-GAL4 bipartite expression system. Compared to wild-type actin, muscle-restricted expression of mutant actin had a dose-dependent effect on flight ability. Moreover, excessive K328Q and K326Q/K328Q actin overexpression induced indirect flight muscle degeneration, a phenotype consistent with hypercontraction observed in other Drosophila myofibrillar mutants. Based on F-actin-Tm and F-actin-Tm-myosin models and on our physiological data, we conclude that acetylating K326 and K328 of actin alters electrostatic associations with Tm and/or myosin and thereby augments contractile properties. Our findings highlight the utility of Drosophila as a model that permits efficient targeted design and assessment of molecular and tissue-specific responses to muscle protein modifications, in vivo.

13 August 2018 in eLife
Verified
Journal Article
Open access
WKWilliam Kronert
William Kronert
KBKaylyn M Bell
Kaylyn M Bell
MVMeera C. Viswanathan
Meera C. Viswanathan
GMGirish Melkani
Girish Melkani
ATAdriana S Trujillo
Adriana S Trujillo
Sanford I. BernsteinSanford I. Bernstein
Sanford I. Bernstein
K146N is a dominant mutation in human β-cardiac myosin heavy chain, which causes hypertrophic cardiomyopathy. We examined howDrosophilamuscle responds to this mutation and integratively analyzed the biochemical, physiological and mechanical foundations of the disease. ATPase assays, actin motility, and indirect flight muscle mechanics suggest at least two rate constants of the cross-bridge cycle are altered by the mutation: increased myosin attachment to actin and decreased detachment, yielding prolonged binding. This increases isometric force generation, but also resistive force and work absorption during cyclical contractions, resulting in decreased work, power output, flight ability and degeneration of flight muscle sarcomere morphology. Consistent with prolonged cross-bridge binding serving as the mechanistic basis of the disease and with human phenotypes,146N/+ hearts are hypercontractile with increased tension generation periods, decreased diastolic/systolic diameters and myofibrillar disarray. This suggests that screening mutatedDrosophilahearts could rapidly identify hypertrophic cardiomyopathy alleles and treatments.

1 September 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
KKKlitos Konstantinidis
Klitos Konstantinidis
VBVassilios J. Bezzerides
Vassilios J. Bezzerides
LLLo Lai
Lo Lai
HIHolly M. Isbell
Holly M. Isbell
AWAn-Chi Wei
An-Chi Wei
MAMark E. Anderson
Mark E. Anderson
Oxidant stress can contribute to health and disease. Here we show that invertebrates and vertebrates share a common stereospecific redox pathway that protects against pathological responses to stress, at the cost of reduced physiological performance, by constraining Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity. MICAL1, a methionine monooxygenase thought to exclusively target actin, and MSRB, a methionine reductase, control the stereospecific redox status of M308, a highly conserved residue in the calmodulin-binding (CaM-binding) domain of CaMKII. Oxidized or mutant M308 (M308V) decreased CaM binding and CaMKII activity, while absence of MICAL1 in mice caused cardiac arrhythmias and premature death due to CaMKII hyperactivation. Mimicking the effects of M308 oxidation decreased fight-or-flight responses in mice, strikingly impaired heart function in Drosophila melanogaster, and caused disease protection in human induced pluripotent stem cell–derived cardiomyocytes with catecholaminergic polymorphic ventricular tachycardia, a CaMKII-sensitive genetic arrhythmia syndrome. Our studies identify a stereospecific redox pathway that regulates cardiac physiological and pathological responses to stress across species.